Evidence map›Paper›PMID 40802384›Full record

ArticleEpidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil2025

Increased maternal and neonatal morbidity and mortality due to severe acute respiratory syndrome in the early years of COVID-19: a descriptive-analytical study, Rio de Janeiro state, Brazil, 2018-2021.

Allan Scharf, Danielle Pereira Paulo, Giselle Ferreira de Paes, Welington Lugão, Danielle Coelho de Azevedo, Beatriz Barde, Nádia Rodrigues

Abstract read
In one paragraph

Article in Epidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Allan ScharfUniversidade Federal de Alagoas, Instituto de Ciências Biológicas e da Saúde, Maceió, AL, Brazil.ORCID http://orcid.org/0000-0001-7579-5598
Danielle Pereira PauloUniversidade do Estado do Rio de Janeiro, Instituto de Medicina Social, Rio de Janeiro, RJ, Brazil.ORCID http://orcid.org/0009-0001-4834-0237
Giselle Ferreira de PaesUniversidade do Estado do Rio de Janeiro, Instituto de Medicina Social, Rio de Janeiro, RJ, Brazil.ORCID http://orcid.org/0000-0002-4574-2601
Welington LugãoUniversidade do Estado do Rio de Janeiro, Instituto de Medicina Social, Rio de Janeiro, RJ, Brazil.ORCID http://orcid.org/0000-0002-8093-1387
Danielle Coelho de AzevedoUniversidade do Estado do Rio de Janeiro, Instituto de Medicina Social, Rio de Janeiro, RJ, Brazil.ORCID http://orcid.org/0009-0002-6755-2582
Beatriz BardeUniversidade do Estado do Rio de Janeiro, Instituto de Medicina Social, Rio de Janeiro, RJ, Brazil.ORCID http://orcid.org/0000-0001-8303-7498
Nádia RodriguesUniversidade do Estado do Rio de Janeiro, Instituto de Medicina Social, Rio de Janeiro, RJ, Brazil.ORCID http://orcid.org/0000-0002-2613-5283

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate morbidity and mortality rates from severe acute respiratory syndrome in pregnant women and newborns in the first two years of the COVID-19 pandemic.

methodsThis was a descriptive-analytical study in which data on cases and deaths in pregnant women and newborns with a positive diagnosis of severe acute respiratory syndrome, regardless of the etiological agent, were collected from the Influenza Epidemiological Surveillance Information System and data on the number of live births from the Live Birth Information System. The frequencies of cases and deaths and the morbidity and mortality rates among pregnant women and newborns in the state of Rio de Janeiro were calculated using the Kruskal-Wallis test to compare the periods 2018-2019 and 2020-2021.

resultsDuring the pandemic, there was a statistically significant increase in morbidity rates in pregnant women (24.49/100,000 to 537.39/100,000; p-value<0.001) and newborns (69.97/100,000 to 200.82/100,000; p-value 0.022) and mortality rates in pregnant women (1.87/100,000 to 48.08/100,000; p-value<0.001) and newborns (1.87/100,000 to 9.26/100,000; p-value 0.008).

conclusionThis study identified a statistically significant increase in morbidity and mortality rates due to severe acute respiratory syndrome in pregnant women and newborns in the state of Rio de Janeiro during the pandemic. There is a clear need for greater investment to reduce harm to these groups, such as vaccination and access to the healthcare system, as well as highly complex infrastructure throughout the state.

Indexed as

COVID-19Pregnancy Complications, InfectiousSevere Acute Respiratory SyndromeAdultBrazilFemaleHumansInfantInfant MortalityInfant, NewbornMaternal MortalityPandemicsPregnancyYoung Adult

Identifiers

PMID40802384
PMCPMC12342852

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.